Emerging Clinical Trials in MDS and Key Takeaways from ASH 2

The panel discusses emerging clinical trials in the MDS treatment space and offers key takeaways from the 2023 ASH Annual Meeting.

Related Keywords

, Evolving Treatment Landscape , Myelodysplastic Syndromes , Clinical Trials , Key Takeaways , Mds , Mds Treatment , Myelodysplastic Syndromes Treatment , Lower Risk Mds , Ker 050 , Variant Allele Frequency , Luspatercept , Roxadustat ,